UBS Group’s Modular Medical MODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29K Sell
623
-72
-10% -$772 ﹤0.01% 9113
2025
Q4
$7.59K Buy
695
+688
+9,829% +$10.1K ﹤0.01% 8433
2025
Q3
$140 Sell
7
-46
-87% -$991 ﹤0.01% 9872
2025
Q2
$1.19K Buy
+53
New +$1.42K ﹤0.01% 9663
2025
Q1
Sell
-164
Closed -$6.74K 10542
2024
Q4
$6.74K Sell
164
-37
-18% -$2.15K ﹤0.01% 8535
2024
Q3
$13.6K Buy
201
+181
+905% +$9.76K ﹤0.01% 7581
2024
Q2
$937 Sell
20
-450
-96% -$22K ﹤0.01% 8727
2024
Q1
$26.1K Buy
470
+261
+125% +$14K ﹤0.01% 6801
2023
Q4
$11.4K Sell
209
-57
-21% -$2.19K ﹤0.01% 7393
2023
Q3
$9.27K Buy
266
+53
+25% +$1.69K ﹤0.01% 7145
2023
Q2
$6.27K Buy
+213
New +$8.64K ﹤0.01% 7380

Other funds holding MODD

UBS Group's MODD Position: Q1 2026 in Review

UBS Group reduced its Modular Medical (MODD) stake by 10% in Q1 2026, selling an estimated $772 and leaving 623 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #9113.

UBS Group first reported a position in MODD in Q2 2023 and has held it in 11 quarters since. The position peaked at $26.1K in Q1 2024. 18 funds tracked by Wall St. Rank hold MODD as of Q1 2026.

  • UBS Group held 623 shares of Modular Medical worth $3.29K as of Q1 2026.
  • UBS Group sold 72 Modular Medical shares in Q1 2026, an estimated $772.
  • Modular Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9113 holding.
  • UBS Group first reported a position in Modular Medical in Q2 2023 and has held it in 11 quarters since.
  • UBS Group's Modular Medical position peaked at $26.1K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Modular Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.